Observational studyJournal of clinical gastroenterology2025

High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel Disease.

Yash Hegde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.